A B S T R A C T Nuclear transfer of androgen receptors (AR) and glucocorticoid receptors (GR) was determined in cultured genital skin fibroblasts from 10 normal controls and eight patients with abnormalities of the external genitalia. In whole cell studies, cultures were incubated for 20 min at 37°C with [3H]methyltrienolone (3H-R1881) or tritiated dexamethasone, and specific binding was determined in whole cell, cytoplasmic, and crude nuclear fractions. Between normal and affected fibroblasts no difference was seen in cellular levels of GR, or in cytoplasmic and nuclear distribution of GR. In normal fibroblasts, cytoplasmic binding of 3H-R1881 represented 56%, and crude nuclear binding 44%, of total binding; in fibroblasts from five of the eight patients similar values (cytoplasmic 55% and nuclear 44%) were seen for 3H-R1881 binding. In fibroblasts from the other three patients no decrease in total cellular levels of AR were seen; nuclear compartmentalization, however, was much lower (-20%) than in other cultures. In vitro reconstitution studies, combining 3H-RI881-loaded cytosol with naive nuclei, lead us to suggest that the defect in nuclear compartmentalization lies at the level of the nuclear acceptor site rather than the cytoplasmic binder in affected cells. We interpret the data to suggest that defective nuclear binding of AR complexes may be involved in a proportion of cases of abnormal development of the external genitalia.
INTRODUCTION
The currently accepted model of steroid hormone action includes an initial step of binding of the hormone to specific cytoplasmic receptors, followed by chromatin binding of these activated steroid-receptor com- plexes, which in turn results in the DNA-directed, RNA-mediated synthesis of specific proteins mediating or constituting the target tissue response (1) .
In testicular feminization, the best-documented clinical disorder of the androgen receptor (AR),' levels of receptor in cultured genital fibroblast cells are usually very low (-10% of normal) or below detection limits (2) (3) (4) (5) . More recently, however, a subgroup of patients with the clinical features of androgen insensitivity has been described, in which group cellular AR levels are normal (6, 7) . Cells from such patients may show absent (6) or normal (7) levels of nuclear accumulation of AR.
The spectrum of clinical disorders in which androgen insensitivity is implicated is now known to be much broader than was previously appreciated. This spectrum includes patients with gynecomastia, infertility, hypospadias, micropenis, and pseudovagina (8, 9) .
In this study, we established genital skin fibroblast cultures from 10 normal controls, and from eight patients with disorders of the external genitalia. In these cultures we determined total receptor levels, and the extent of cytoplasmic and nuclear localization of receptors, after incubation under defined conditions (20 min, 37°C) with near-saturating concentrations of androgen ( Fibroblast strains in these studies were established from genital skin explants obtained from normal patients (6 mo-9 yr) and affected patients (6 mo-16 yr) . Procedures for the maintenance and storage of these strains were as described by Griffin et al. (4 98±2% (mean±SEM, n = 18). In parallel studies, equivalent nuclear recovery and nuclear/cytoplasmic compartmentalization of AR were seen when cells were lysed by freeze-thawing in dry ice-ethanol.
For reconstitution studies, cells were suspended, an aliquot counted, and the remainder disrupted by dry ice-ethanol freeze-thawing in 1 ml TEDG buffer (10 mM Tris, 2 mM EDTA, 1.5 mM dithiothreitol, 10% vol/vol glycerol, pH 7.4 at 0°C). Nuclei were pelleted by centrifugation at 600 g for 10 minutes. The supernatant cytoplasmic fraction was diluted to 3 ml with TEDG buffer, and aliquots incubated with 5 nM 3H-R1881 for 4 h at 4°C, in the presence and absence of 100-fold DHT. Residual free 3H-R11881 was removed with charcoal, and the 3H-RI881-receptor complexes activated by heating for 15 min at 25°C.The cytosol was cooled to 4°C, and 200-!u aliquots of naive nuclei (-2-4 X 10' nuclei/ The penile skin biopsy from patient HS-35b was obtained at the time of hypospadias repair. The only abnormality noted was a coronal hypospadias; the phallus was measured and was normal in size (5 X 1.8 cm), as were the testes. The patient had no previous investigations, and was lost to followup for 2 yr. Recently the patient was found, and a blood sample taken 72 h after 5,000 U HCG showed a testosterone level (10.9 nM) in the normal adult range.
RESULTS
Total cellular AR and glucocorticoid receptor (GR) levels, and the distribution between cytoplasmic and nuclear compartments are shown in Table III Tables III and IV . Patient 2 (HS-36) is perhaps worthy of special attention, in that total cellular levels of androgen receptor (11.9 fmol/106 cells) were the second-highest recorded in all 18 cell lines detailed; despite this fact, the percentage transfer of 'H-R1881 in this patient was consistently below the normal range.
The results of a limited series of in vitro reconstitution experiments are shown in Table VI . Cytosol from normal fibroblasts (NC26, NC4, NC17) and from the three patients with low percentage nuclear com- partmentalization was found to be equivalent as a source of AR, in that nuclei from normal, steroid unexposed cells bound equivalent levels. In contrast, however, nuclei from all three patients bound much lower levels of cytoplasmic AR, whether the source was their own or normal cytoplasm.
DISCUSSION
The findings described in this paper appear worthy of discussion under several headings. First, the disorder at a subcellular level appears not to be one of an abnormal receptor, but of a lowered number of nuclear binding sites for androgen receptors. In contrast, the primary defect in most patients with testicular feminization appears to reside at the level of the cytoplasmic androgen receptor, in that minimal or absent androgen binding is found.
In a minority of cases of incomplete male pseudohermaphroditism, normal androgen receptor levels with normal (7) or impaired (6) nuclear transfer have been reported. The impairment of nuclear transfer in the latter instance has been suggested to be a reflection of a receptor abnormality, rather than abnormal nuclear acceptor sites. Similarly, of the many S-49 lymphoma cell line mutants resistant to DM, and with decreased (or increased) nuclear localization, the defect has always appeared to be present in the receptor and not in the nuclear acceptor sites (10) . One interpretation of this finding is that the selection system used for such mutants (growth in 100 nM DM) imposes conditions under which only certain classes of steroidunresponsive variants survive.
Consistent with the clinical presentation of incomplete androgenization, rather than complete androgen insensitivity, cells from the patients described in this study showed consistently and significantly lower, but not absent, nuclear binding of AR complexes. Under the conditions of assay, cytoplasmic/nuclear compartmentalization of AR in normal cells is at equilibrium after 20 min incubation. There are two possible interpretations of this -60% cytoplasmic/40% nuclear localization of androgen receptors, at near-saturating 3H-R1881 concentrations. The first is that the affinity with which androgen-receptor complexes are bound to acceptor sites is relatively weak, so that the bulk of the complexes remain unbound in the cytoplasm. The second possibility is that the nuclear acceptor sites have a high affinity, but limited capacity, for androgen-receptor complexes, and that the nuclear acceptor sites are all essentially occupied at this concentration of 3H-R1881 under the incubation conditions used.
The interpretation of an altered ratio of cytoplasmic to nuclear localization is dependent on whether one or both of the above mechanisms is limiting. If the affinity with which nuclear acceptor sites bind AR complexes is modest, then an overall fall in the affinity of the whole population of nuclear acceptor sites would be reflected in an overall fall in nuclear localization, as was seen in these three patients. Conversely, if the affinity of the acceptor site-receptor complex interaction is high, and the capacity of the nuclear acceptor system limiting, a similar fall in overall acceptor affinity would minimally affect compartmentalization; in contrast, a fall in the number of nuclear acceptor sites would be reflected very closely by lowered nuclear accumulation, as was seen in these studies.
On the basis of the evidence available from the present studies it is not possible to select between these possibilities. While intuitively the latter may sound more plausible, and is strongly supported by the comparable nuclear accumulation by normal nuclei in whole cell and in reconstitution studies, the two possibilities outlined above are in fact nonexclusive. In normal cells, acceptor site capacity may be limiting; in affected cells a substantial reduction in affinity of all acceptor sites for AR complexes may occur, so that both the altered affinity and an unchanged, limited capacity become determinants of nuclear localization. Two of the three patients with defective nuclear transfer were given testosterone, and both responded positively in terms of penile growth. Though in neither case was the response particularly marked, we interpret this response to indicate that high ambient testosterone concentrations can be followed by increased expression of androgen-inducible genes in these patients.
Whatever the molecular mechanism of the impaired nuclear binding of AR complexes, it does not appear to affect nuclear binding of GR complexes, which was equivalent in all cells tested. Secondly, though glucocorticoid transfer studies were performed on only eight patients with genital abnormalities, normal AR levels and compartmentalization were found in a further 21. The incidence of defective nuclear acceptor sites, as a presumptive cause of incomplete androgenization, is therefore more likely to be of the order of 10% than the -40% that might otherwise be assumed.
Currently, studies are directed at establishing the incidence of defective nuclear transfer of AR complexes in a range of disorders of partial androgen insensitivity, and to determine the molecular mechanisms involved in such defective nuclear binding.
